MedTrace Logo

Karolinska Schizophrenia Project

NCT06872463 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-03-12

No results posted yet for this study

Summary

KaSP is a multimodal observational study with the goal of clarifying underlying mechanisms that cause psychotic disorders, such as schizophrenia. Participants with psychotic symptoms are recruited early after first contact with health care, within 4 weeks of starting anti-psychotic medication, and are compared to controls without psychiatric diagnoses on several measures.

Conditions

  • Schizophrenia and Disorders with Psychotic Features

Sponsors & Collaborators

  • Centre for Psychiatry Research, Region Stockholm, Sweden

    collaborator UNKNOWN

  • Karolinska Institutet

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-25
Primary Completion
2027-12-31
Completion
2032-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06872463 on ClinicalTrials.gov